Abstract
Background and Objectives
5-hydroxytryptamine3 (5-HT3) receptor antagonists have been commonly used to reduce propofol injection pain. The aim of this meta-analysis was to evaluate the efficacy and safety of 5-HT3 receptor antagonists in decreasing the incidence and intensity of propofol injection pain.
Methods
Online databases of Pubmed, Embase and the Cochrane Central Register of Controlled Trials were searched as well as reference lists of included studies and recent reviews. Eligible randomized controlled trials (RCTs) assessing the efficacy and safety of 5-HT3 receptor antagonists for propofol injection pain were identified. The outcomes included the incidence and intensity of propofol injection pain and adverse effects. We calculated risk ratios (RR) with 95 % confidence intervals (CIs) for dichotomous data and adopted fixed or random-effects model when proper.
Results
A total of eight RCTs were included in the final analysis. Compared with the control group, 5-HT3 receptor antagonists were related to a decreasing incidence of propofol injection pain (RR 0.43, 95 % CI 0.33–0.56, P < 0.05). Besides, they also effectively alleviated the severity of propofol injection pain. They significantly reduced the number of patients with moderate (RR 0.21, 95 % CI 0.15–0.30, P < 0.05) and severe pain (RR 0.16, 95 % CI 0.10–0.25, P < 0.05) during propofol injection. 5-HT3 receptor antagonists and lidocaine were equally effective in preventing propofol injection pain. Moreover, only one article mentioned the adverse effects of 5-HT3 receptor antagonists in two patients.
Conclusion
Our meta-analysis indicates that 5-HT3 receptor antagonists can effectively reduce the incidence and severity of propofol injection pain. Additionally, 5-HT3 receptor antagonists may become the alternatives to lidocaine in attenuating propofol injection pain. However, evidence is still limited for the safety of 5-HT3 receptor antagonists on propofol injection pain.
Similar content being viewed by others
References
Bateman BT, Kesselheim AS. Propofol as a transformative drug in anesthesia: insights from key early investigators. Drug Discov Today. 2015;20:1012–7.
Macario A, Weinger M, Truong P, et al. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg. 1999;88:1085–91.
Jalota L, Kalira V, George E, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011;342:d1110.
Hanci V, Ayoglu H, Yilmaz M, et al. Effect of menstrual cycle on the injection pain due to propofol. Eur J Anaesthesiol. 2010;27:425–7.
Fletcher GC, Gillespie JA, Davidson JA. The effect of temperature upon pain during injection of propofol. Anaesthesia. 1996;51:498–9.
Huang CL, Wang YP, Cheng YJ, et al. The effect of carrier intravenous fluid speed on the injection pain of propofol. Anesth Analg. 1995;81:1087–8.
Davies AF, Vadodaria B, Hopwood B, et al. Efficacy of microfiltration in decreasing propofol-induced pain. Anaesthesia. 2002;57:557–61.
Soltesz S, Diekmann M, Mitrenga-Theusinger A, et al. Reduced pain on injection with a 0.5 % propofol emulsion during induction of anesthesia. Eur J Anaesthesiol. 2012;29:162–3.
Fahringer DL, Goodwin SR, Warde MK, et al. The effect of a 3: 1 volume mixture of propofol 1 % and thiopental 2.5 % in reducing the pain on injection of propofol in children. Paediatr Anaesth. 2010;20:545–52.
Kim K, Sung Kim Y, Lee DK, et al. Reducing the pain of microemulsion propofol injections: a double-blind, randomized study of three methods of tourniquet and lidocaine. Clin Ther. 2013;35:1734–43.
Machu TK. Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions. Pharmacol Ther. 2011;130:338–47.
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Cho YH, Kim CK, Heo KH, et al. Acupuncture for acute postoperative pain after back surgery: a systematic review and meta-analysis of randomized controlled trials. Pain Pract. 2015;15:279–91.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical researched). 1997;315:629–34.
Rahimzadeh P, Faiz SH, Nikoobakht N, et al. Which one is more efficient on propofol 2 % injection pain? Magnesium sulfate or ondansetron: a randomized clinical trial. Adv Biomed Res. 2015;4:56.
Singh DK, Jindal P, Singh G. Comparative study of attenuation of the pain caused by propofol intravenous injection, by granisetron, magnesium sulfate and nitroglycerine. Saudi J Anaesth. 2011;5:50–4.
Reddy MS, Chen FG, Ng HP. Effect of ondansetron pretreatment on pain after rocuronium and propofol injection: a randomised, double-blind controlled comparison with lidocaine. Anaesthesia. 2001;56:902–5.
Memis D, Turan A, Karamanlioglu B, et al. The prevention of propofol injection pain by tramadol or ondansetron. Eur J Anaesthesiol. 2002;19:47–51.
Lee KH, Rim SK, Lee JY, et al. Effects of pretreatment with intravenous palonosetron for propofol-remifentanil-based anesthesia in breast and thyroid cancer surgery: A double-blind, randomized, controlled study. Korean J Anesthesiol. 2014;67:13–9.
Ryu HB, Kim SJ. Analgesic effects of palonosetron in the intravenous propofol injection. Korean J Anesthesiol. 2014;66:99–104.
Singh D, Jagannath S, Priye S, et al. Prevention of propofol injection pain: comparison between lidocaine and ramosetron. J Anaesthesiol Clin Pharmacol. 2014;30:213–6.
Lee HY, Kim SH, So KY. Prevention of microemulsion propofol injection pain: A comparison of a combination of lidocaine and ramosetron with lidocaine or ramosetron alone. Korean J Anesthesiol. 2011;61:30–4.
Ahmed A, Sengupta S, Das T, et al. Pre-treatment with intravenous granisetron to alleviate pain on propofol injection: A double-blind, randomized, controlled trial. Indian J Anaesth. 2012;56:135–8.
Dubey PK, Prasad SS. Pain on injection of propofol: The effect of granisetron pretreatment. Clin J Pain. 2003;19:121–4.
Alipour M, Tabari M, Alipour M. Paracetamol, ondansetron, granisetron, magnesium sulfate and lidocaine and reduced propofol injection pain. Iran Red Crescent Med J. 2014;16:e16086.
Zahedi H, Maleki A, Rostami G. Ondansetron pretreatment reduces pain on injection of propofol. Acta Med Iran. 2012;50:239–43.
Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blinded study. Anesth Analg. 1999;89:197–9.
Moher D, Liberati A, Tetzlaff J, et al. Reprint–preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89:873–80.
McCrirrick A, Hunter S. Pain on injection of propofol: the effect of injectate temperature. Anaesthesia. 1990;45:443–4.
Shimizu T, Inomata S, Tanaka M. Rapid injection of propofol reduces vascular pain and facilitates Laryngeal Mask Airway insertion. J Clin Anesth. 2011;23:540–3.
Dedic A, Adam S, Gommers D, et al. Propofol injection pain: is it still an issue? The effect of premedication. Minerva Anestesiol. 2010;76:720–4.
Stokes DN, Robson N, Hutton P. Effect of diluting propofol on the incidence of pain on injection and venous sequelae. Br J Anaesth. 1989;62:202–3.
King SY, Davis FM, Wells JE, et al. Lidocaine for the prevention of pain due to injection of propofol. Anesth Analg. 1992;74:246–9.
Fujii Y, Itakura M. Efficacy of the lidocaine/flurbiprofen axetil combination for reducing pain during the injection of propofol. Minerva Anestesiol. 2011;77:693–7.
Gehan G, Karoubi P, Quinet F, et al. Optimal dose of lignocaine for preventing pain on injection of propofol. Br J Anaesth. 1991;66:324–6.
Borazan H, Erdem TB, Kececioglu M, et al. Prevention of pain on injection of propofol: a comparison of lidocaine with different doses of paracetamol. Eur J Anaesthesiol. 2010;27:253–7.
Kazemi-Kjellberg F, Henzi I, Tramer MR. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol. 2001;1:2.
Ye JH, Mui WC, Ren J, et al. Ondansetron exhibits the properties of a local anesthetic. Anesth Analg. 1997;85:1116–21.
Gregory RE, Ettinger DS. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Drugs. 1998;55:173–189.
Farouk S. Ondansetron added to lidocaine for intravenous regional anaesthesia. Eur J Anaesthesiol. 2009;26:1032–6.
Honarmand A, Safavi M, Adineh-Mehr L. Effect of adding 8 milligrams ondansetron to lidocaine for Bier’s block on post-operative pain. Adv Biomed Res. 2013;2:52.
Azimaraghi O, Aghajani Y, Molaghadimi M, et al. Ondansetron reducing pain on injection of etomidate: a controlled randomized study. Braz J Anesthesiol. 2014;64:169–72.
Salvo N, Doble B, Khan L, et al. Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials. Int J Radiat Oncol Biol Phys. 2012;82:408–17.
Author information
Authors and Affiliations
Corresponding author
Additional information
W. Wang and L. Zhou contribute equally to this article and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Wang, W., Zhou, L., Wu, LX. et al. 5-HT3 Receptor Antagonists for Propofol Injection Pain: A Meta-Analysis of Randomized Controlled Trials. Clin Drug Investig 36, 243–253 (2016). https://doi.org/10.1007/s40261-016-0375-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-016-0375-1